Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Give
Donate Today
Memorial/Tribute (make donation)
Create Event or Memorial Page
Find a Memorial/Tribute Page
Planned Giving
Stock/Securities Donations / IRA Charitable Rollovers
Other Giving Opportunities
Research Partners
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Watch
Healthy Minds TV
Meet the Scientists Webinars
Videos
Connect
Ask the Expert
Join Us
Home
Grants
Grant FAQs
NARSAD Young Investigator Grants
NARSAD Independent Investigator Grants
NARSAD Distinguished Investigator Grants
Prizes & Awards
Klerman & Freedman Prizes
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
The Pardes Humanitarian Prize
Productive Lives Awards
Blog
About Us
Who We Are
Our Impact
FAQs
Media Center
News
Press Releases
Opinion Pieces
In the News
Multimedia Library
Media Kit
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

PTSD

Brain Matters
Blog

Will Ketamine Be A Breakthrough Drug for PTSD?
Ketamine for PTSD treatment

A fresh generation of fast-acting anti-depressants is in the offing, says John H.

Read More
A New Hope for Treating Post-Traumatic Stress Disorder (PTSD)
https://www.bbrfoundation.org/content/treatment-immune-regulating-gut-bacteria-may-boost-immune-system-against-stress

Foundation President and CEO, Jeffrey Borenstein, M.D. is quoted in an article from Scientific American about a research study featured in the Foundation's top 10 research advancements of 2016.

Read More

TOPICS

Blog Tag

Research News
Anxiety
Depression
Addiction
BBRF News
Mental Illness (General)
PTSD
Borderline Personality Disorder
Advice on Mental Health Disorders
Bipolar Disorder
Suicide
Supporter Stories
Eating Disorders
Schizophrenia
Mental Health and Society
Recovery Stories
Autism
BBRF Webinars
Transcripts